Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With no Response to Leishmanin

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

May 31, 2007

Study Completion Date

December 31, 2007

Conditions

Healthy

Interventions

BIOLOGICAL

Alum-ALM + BCG

Alum precipitated autoclaved L. major

BIOLOGICAL

Alum-ALM + BCG

Arm 1=Alum-ALM + BCG Arm 2=BCG Arm 3=Placebo comparator

BIOLOGICAL

Alum-ALM + BCG

Trial Locations (1)

Center for Research & Training in Skin Diseases & Leprosy, TUMS, Tehran

All Listed Sponsors

collaborator

Pasteur Institute of Iran, Tehran, Iran

UNKNOWN

collaborator

Razi Vaccine and Serum Research Institute

OTHER

collaborator

Centre for Disease Control & Management, Ministry of Health & Medical Education

OTHER_GOV

lead

Tehran University of Medical Sciences

OTHER

NCT00429715 - Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With no Response to Leishmanin | Biotech Hunter | Biotech Hunter